Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
Vaxcyte (PCVX) Stock Price & Analysis
123 Followers
PCVX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.44 - $49.31
Previous Close$36.85
Volume773.70K
Average Volume (3M)661.09K
Market Cap
$2.95B
Enterprise Value$2.04B
Total Cash (Recent Filing)$931.38M
Total Debt (Recent Filing)$17.94M
Price to Earnings (P/E)-10.7
Beta1.07
Next Earnings
May 09, 2023EPS Estimate
-$0.83Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.44
Shares Outstanding80,033,727
10 Day Avg. Volume806,823
30 Day Avg. Volume661,085
Standard Deviation0.20
R-Squared0.07
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)3.18
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-17.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-9.50
Forecast
1Y Price Target
$63.50Price Target Upside75.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Vaxcyte News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PCVX FAQ
What was Vaxcyte, Inc.’s price range in the past 12 months?
Vaxcyte, Inc. lowest stock price was $17.44 and its highest was $49.31 in the past 12 months.
What is Vaxcyte, Inc.’s market cap?
Currently, no data Available
When is Vaxcyte, Inc.’s upcoming earnings report date?
Vaxcyte, Inc.’s upcoming earnings report date is May 09, 2023 which is in 39 days.
How were Vaxcyte, Inc.’s earnings last quarter?
Vaxcyte, Inc. released its earnings results on Feb 27, 2023. The company reported -$1.03 earnings per share for the quarter, missing the consensus estimate of -$0.93 by -$0.1.
Is Vaxcyte, Inc. overvalued?
According to Wall Street analysts Vaxcyte, Inc.’s price is currently Undervalued.
Does Vaxcyte, Inc. pay dividends?
Vaxcyte, Inc. does not currently pay dividends.
What is Vaxcyte, Inc.’s EPS estimate?
Vaxcyte, Inc.’s EPS estimate is -$0.83.
How many shares outstanding does Vaxcyte, Inc. have?
Vaxcyte, Inc. has 80,033,730 shares outstanding.
What happened to Vaxcyte, Inc.’s price movement after its last earnings report?
Vaxcyte, Inc. reported an EPS of -$1.03 in its last earnings report, missing expectations of -$0.93. Following the earnings report the stock price went down -3.144%.
Which hedge fund is a major shareholder of Vaxcyte, Inc.?
Among the largest hedge funds holding Vaxcyte, Inc.’s share is RA Capital Management. It holds Vaxcyte, Inc.’s shares valued at 281M.
---
Vaxcyte Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$63.50 (75.08% Upside)
$63.50 (75.08% Upside)
Blogger Sentiment
Bullish
PCVX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 3.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $157.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.94%
12-Months-Change
Fundamentals
Return on Equity
-36.11%
Trailing 12-Months
Asset Growth
210.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vaxcyte, Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from most common and deadly diseases.
---
Top 5 ETFs holding PCVX
Fidelity Nasdaq Composite Index ETF
$1.07M
Fidelity Growth Opportunities ETF
$369.97K
Up to five ETFs with an Outperform Smart Score that hold PCVX. The ETFs are listed according to market value of PCVX within the ETF
---
---